-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Disc Medicine, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- Disc Medicine, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.9M, a 73.3% decline year-over-year.
- Disc Medicine, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$125M, a 63.4% decline year-over-year.
- Disc Medicine, Inc. annual Operating Income (Loss) for 2023 was -$91.1M, a 91.9% decline from 2022.
- Disc Medicine, Inc. annual Operating Income (Loss) for 2022 was -$47.5M, a 53.5% decline from 2021.
- Disc Medicine, Inc. annual Operating Income (Loss) for 2021 was -$30.9M, a 9.13% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)